LON: REDX 55.13GBX

Notice of Preliminary ResultsNew Trinity Delta Research Report PublishedResults of Open Offer and General Meeting

Redx
  • About us
    • About us
    • Board of Directors
    • Executive Management
    • Expert Advisers
  • Our pipeline
    • Our pipeline
    • RXC004 (Porcupine Inhibitor)
    • RXC007 (ROCK2 selective)
    • Research programmes
      • Oncology
      • Fibrosis
      • GI-targeted ROCK inhibitor
    • Partnered programmes
      • RXC006 (Porcupine inhibitor, Fibrosis)
      • Pan-RAF Inhibitor
      • RXC005 (now LOXO-305) Reversible BTK inhibitor
  • Our science
    • Our scientific publications
  • Investors
    • Investor centre
    • Report & Accounts
    • Presentations, analyst reports, documents & videos
    • Regulatory news
    • AIM Rule 26
    • QCA Corporate Governance Code
    • Email alerts
  • News & events
    • News & events
  • Contact us
    • Contact us
    • Careers
  • About us
    • About us
    • Business model & strategy
    • Board of Directors
    • Executive Management
    • Expert Advisers
  • Our pipeline
    • Pipeline
    • RXC004 (Porcupine Inhibitor)
    • RXC007 (ROCK 2 Selective)
    • Research programmes
      • Oncology
      • Fibrosis
      • GI targeted ROCK
    • Partnered programmes
      • RXC006 (Porcupine Fibrosis)
      • Pan – RAF
      • RXC005 (BTK)
  • Our science
    • Our scientific publications
  • Investors
    • Investor centre
    • Report & Accounts
    • Presentations, analyst reports, documents & videos
    • Regulatory news
    • AIM Rule 26
    • QCA Corporate Governance Code
    • Email alerts
  • News & Events
    • News & events
  • Contact
    • Contact us
    • Careers

Top suggestions

  • Notice of Preliminary Results
  • New Trinity Delta Research Report Published
  • Results of Open Offer and General Meeting
  • Notice of Preliminary Results

    Read more
Redx

Copyright © 2021 Redx Pharma Plc

  • Privacy policy
  • Cookie policy

Website design & build by Carr Kamasa Design

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies. Cookie Policy.